
vTv Therapeutics Inc.: shareholders and insiders
Price
$15.51
November 20, 2026Market cap $62M
What Ploutos Investor adds for vTv Therapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 13 fiscal years, from 2013
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 29% since Nov 5, 2026, when the 10-Q these figures come from was filed ($21.74 then, $15.51 on Nov 20, 2026). The figures date from before that move.10-Q
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Sorry, we do not have enough data
for purchases and sales by vTv Therapeutics's insiders
Why?
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Samsara BioCapital, L.P.with 4 more personsClass A Common Stock, par value $0.01 per shareShare of class9.90%
- Trails Edge Capital Partners, LPwith 2 more personsShare of class9.90%
- Invus Public Equities, L.P.with 7 more personsClass A Common Stock, $0.01 par value per shareShare of class9.40%
- Integrated Core Strategies (US) LLCwith 3 more personsClass A Common Stock, par value $0.01 per shareShare of class8.70%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Samsara BioCapital, L.P.with 4 more personsClass A Common Stock, par value $0.01 per share | 9.90% | 403.9K | Dec 9, 20253 filings since Sep 3, 2025 | 13D/A | |
| Trails Edge Capital Partners, LPwith 2 more persons | 9.90% | 340.5K | Sep 8, 2025 | 13G | |
| Invus Public Equities, L.P.with 7 more personsClass A Common Stock, $0.01 par value per share | 9.40% | 393.1K | Nov 12, 20252 filings since Sep 8, 2025 | 13G/A | |
| Integrated Core Strategies (US) LLCwith 3 more personsClass A Common Stock, par value $0.01 per share | 8.70% | 342.5K | Oct 8, 20264 filings since Mar 27, 2026 | 13G/A |
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Millennium Mgmt (Englander)In the quarter+27%
- Point72 (Cohen)In the quarter
- Citadel Advisors (Griffin)In the quarter
- Renaissance TechnologiesIn the quarter+22%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Millennium Mgmt (Englander) | 342.5K | +27% | $11M | 0.01% |
| Point72 (Cohen) | – | – | 0.00% | |
| Citadel Advisors (Griffin) | – | – | 0.00% | |
| Renaissance Technologies | 21.3K | +22% | $700.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 3.57% of its shares outstanding were held short, -8.5% since the report before.
- Shares held short
- 143.4K
- 3.57%
- Since the report before156.8K on Sep 30, 2026
- -8.5%
- 5.7
- 25.3K
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 1.18M
- Nov 15, 2023: Shares held short 1.14M
- Nov 30, 2023: Shares held short 35.5K
- Dec 15, 2023: Shares held short 39.2K
- Dec 29, 2023: Shares held short 50.1K
- Jan 12, 2024: Shares held short 39.7K
- Jan 31, 2024: Shares held short 70.9K
- Feb 15, 2024: Shares held short 43.2K
- Feb 29, 2024: Shares held short 38.0K
- Mar 15, 2024: Shares held short 57.2K
- Mar 28, 2024: Shares held short 32.2K
- Apr 15, 2024: Shares held short 28.8K
- Apr 30, 2024: Shares held short 26.6K
- May 15, 2024: Shares held short 23.8K
- May 31, 2024: Shares held short 18.6K
- Jun 14, 2024: Shares held short 21.9K
- Jun 28, 2024: Shares held short 19.6K
- Jul 15, 2024: Shares held short 19.4K
- Jul 31, 2024: Shares held short 28.2K
- Aug 15, 2024: Shares held short 38.1K
- Aug 30, 2024: Shares held short 33.1K
- Sep 13, 2024: Shares held short 31.0K
- Sep 30, 2024: Shares held short 31.5K
- Oct 15, 2024: Shares held short 29.0K
- Oct 31, 2024: Shares held short 28.9K
- Nov 15, 2024: Shares held short 27.2K
- Nov 29, 2024: Shares held short 22.5K
- Dec 13, 2024: Shares held short 16.9K
- Dec 31, 2024: Shares held short 16.9K
- Jan 15, 2025: Shares held short 22.5K
- Jan 31, 2025: Shares held short 26.7K
- Feb 14, 2025: Shares held short 27.9K
- Feb 28, 2025: Shares held short 24.1K
- Mar 14, 2025: Shares held short 24.5K
- Mar 31, 2025: Shares held short 16.1K
- Apr 15, 2025: Shares held short 22.9K
- Apr 30, 2025: Shares held short 21.6K
- May 15, 2025: Shares held short 16.3K
- May 30, 2025: Shares held short 18.7K
- Jun 13, 2025: Shares held short 18.0K
- Jun 30, 2025: Shares held short 18.3K
- Jul 15, 2025: Shares held short 14.6K
- Jul 31, 2025: Shares held short 15.2K
- Aug 15, 2025: Shares held short 15.8K
- Aug 29, 2025: Shares held short 14.7K
- Sep 15, 2025: Shares held short 17.1K
- Sep 30, 2025: Shares held short 21.5K
- Oct 15, 2025: Shares held short 22.8K
- Oct 31, 2025: Shares held short 19.5K
- Nov 14, 2025: Shares held short 21.1K
- Nov 28, 2025: Shares held short 19.1K
- Dec 15, 2025: Shares held short 16.7K
- Dec 31, 2025: Shares held short 27.1K
- Jan 15, 2026: Shares held short 30.9K
- Jan 30, 2026: Shares held short 31.5K
- Feb 13, 2026: Shares held short 50.8K
- Feb 27, 2026: Shares held short 57.1K
- Mar 13, 2026: Shares held short 66.0K
- Mar 31, 2026: Shares held short 82.2K
- Apr 15, 2026: Shares held short 112.7K
- Apr 30, 2026: Shares held short 137.0K
- May 15, 2026: Shares held short 144.6K
- May 29, 2026: Shares held short 157.3K
- Jun 15, 2026: Shares held short 158.5K
- Jun 30, 2026: Shares held short 163.7K
- Jul 15, 2026: Shares held short 172.2K
- Jul 31, 2026: Shares held short 165.8K
- Aug 14, 2026: Shares held short 166.0K
- Aug 31, 2026: Shares held short 162.9K
- Sep 15, 2026: Shares held short 160.3K
- Sep 30, 2026: Shares held short 156.8K
- Oct 15, 2026: Shares held short 143.4K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading57.0% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 57.0% of the shares in the reported trades were short sales, against 49.5% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 57.0%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 49.5%
- Change
- +7.5 pts
- Short sales a dayon average, of 5,656 shares
- 3,225
- More than atof 3,666 US-listed companies, same days
- 74%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 71%
- Oct 15, 2026: Short sales 78.6%
- Oct 16, 2026: Short sales 25.5%
- Oct 19, 2026: Short sales 48.5%
- Oct 20, 2026: Short sales 76.8%
- Oct 21, 2026: Short sales 67.3%
- Oct 22, 2026: Short sales 46.8%
- Oct 23, 2026: Short sales 39.7%
- Oct 26, 2026: Short sales 38.1%
- Oct 27, 2026: Short sales 49.6%
- Oct 28, 2026: Short sales 47.1%
- Oct 29, 2026: Short sales 54.3%
- Oct 30, 2026: Short sales 49.2%
- Nov 2, 2026: Short sales 26.8%
- Nov 3, 2026: Short sales 24.3%
- Nov 4, 2026: Short sales 33.3%
- Nov 5, 2026: Short sales 40.5%
- Nov 6, 2026: Short sales 77.9%
- Nov 9, 2026: Short sales 23.5%
- Nov 10, 2026: Short sales 70%
- Nov 11, 2026: Short sales 70.8%
- Nov 12, 2026: Short sales 65.5%
- Nov 13, 2026: Short sales 69%
- Nov 16, 2026: Short sales 67.7%
- Nov 17, 2026: Short sales 75.6%
- Nov 18, 2026: Short sales 45.4%
- Nov 19, 2026: Short sales 75.9%
- Nov 20, 2026: Short sales 68.3%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.02%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
| ETF | Weight in the fund | Holdings as of |
|---|---|---|
| IWCiShares Micro-Cap ETF | 0.02% | Jun 30, 2026 |
| VXFVanguard Extended Market Index Fund | 0.00% | Jun 30, 2026 |
| VTIVanguard Total Stock Market Index Fund | 0.00% | Jun 30, 2026 |
3 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 23
- Q4 2025: Managers 27
- Q1 2026: Managers 35
- Q2 2026: Managers 45
Institutional investors by quarter
The fund managers holding VTVT, quarter by quarter, from Q3 2015 to Q2 2025, 40 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 45 managers held 1.61M shares, worth $61M. During the quarter 17 opened a position, 7 closed one, 5 added and 8 trimmed.
The largest holders, Q2 2026
- Samsara BiocapitalIn the quarter
- Millennium Mgmt (Englander)In the quarter+31%
- FMRIn the quarter
- SirenIn the quarter
- Baker Bros. AdvisorsIn the quarter
- Vanguard Capital ManagementIn the quarter-13%
- Trails Edge Capital PartnersIn the quarter-39%
- Aisling Capital ManagementIn the quarter
- Marshall WaceIn the quarter+195%
- Geode Capital ManagementIn the quarter-1.3%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Samsara Biocapital | 298.5K | $11M | |
| Millennium Mgmt (Englander) | 269.9K | +31% | $10M |
| FMR | 260.4K | $9.8M | |
| Siren | 163.0K | $6.1M | |
| Baker Bros. Advisors | 148.3K | $5.6M | |
| Vanguard Capital Management | 94.5K | -13% | $3.6M |
| Trails Edge Capital Partners | 85.2K | -39% | $3.2M |
| Aisling Capital Management | 50.0K | $1.9M | |
| Marshall Wace | 39.6K | +195% | $1.5M |
| Geode Capital Management | 32.5K | -1.3% | $1.2M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do vTv Therapeutics's filings show?
Who buys and sells is one part of vTv Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have VTVT's insiders bought or sold?
From Jun 29, 2026 to Jun 29, 2026 vTv Therapeutics's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold VTVT?
4 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $11M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.